TR

Active Director Director DIN 08115898
DIN 08115898 First appointment Apr 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2018
Shareholding value •••• Premium profile

About Tilak Raj

Data last updated:

Tilak Raj is a Director at Afflatus Pharmaceuticals Private Limited (since 2018). The company operates in Healthcare. Afflatus Pharmaceuticals Private Limited reported revenue of ₹35.04 Cr (FY 2025).

DIN 08115898
Primary Designation Director
Industry Healthcare
First Appointment 23 Apr 2018
Oldest Company Age 21 yrs
Largest company Afflatus Pharmaceuticals Private Limited · ₹35.04 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Apr 20182005₹35.04 Cr (FY 2025)Active

Board colleagues of Tilak Raj

NameDINCompanyDesignation
Kamal Chhabra08113296Afflatus Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Afflatus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Tilak Raj

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tilak Raj

Tilak Raj currently holds 1 directorship: Afflatus Pharmaceuticals Private Limited (Director, since 23 Apr 2018, revenue ₹35.04 Cr (FY 2025)).

Tilak Raj was first appointed on 23 Apr 2018 as Director at Afflatus Pharmaceuticals Private Limited.

The current boards of Tilak Raj's companies include Kamal Chhabra (Afflatus Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available